Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bromberg

Showing results (141-150 of 358) with videos related to

Pageof 36
Sort By:
Annals of Surgery|October 1, 1993
Combination anti-CD2 and anti-CD3 monoclonal antibodies induce tolerance while altering interleukin-2, interleukin-4, tumor necrosis factor, and transforming growth factor-beta productionK D Chavin, L Qin, J Lin, et al.
BMC Nephrology|October 11, 2013
An update on the impact of pre-transplant transfusions and allosensitization on time to renal transplant and on allograft survivalJuan C Scornik, Jonathan S Bromberg, Douglas J Norman, et al.
ACS Biomaterials Science & Engineering|December 10, 2020
Engineering Strategies to Improve Islet Transplantation for Type 1 Diabetes TherapyAlisa M White, James G Shamul, Jiangsheng Xu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 2, 2002
L-selectin-dependent lymphoid occupancy is required to induce alloantigen-specific toleranceYalai Bai, Jianhua Liu, Yinong Wang, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 31, 2002
CD2 is a dominant target for allogeneic responsesYalai Bai, Shuang Fu, Shaun Honig, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 1, 1994
Prevalence of p53 mutations in patients with squamous cell carcinoma of the esophagusC E Gates, C E Reed, J S Bromberg, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 5, 2003
Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxisEnver Akalin, Vinita Sehgal, Scott Ames, et al.
Neuron|June 12, 2021
A prefrontal network integrates preferences for advance information about uncertain rewards and punishmentsAhmad Jezzini, Ethan S Bromberg-Martin, Lucas R Trambaiolli, et al.
Human Gene Therapy|December 31, 1997
Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expressionL Qin, Y Ding, D R Pahud, et al.
Human Gene Therapy|July 20, 1997
Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigenL Qin, Y Ding, D R Pahud, et al.
Pageof 36

Showing results (141-150 of 358) with videos related to

Sort By:
Pageof 36
Annals of Surgery|October 1, 1993
Combination anti-CD2 and anti-CD3 monoclonal antibodies induce tolerance while altering interleukin-2, interleukin-4, tumor necrosis factor, and transforming growth factor-beta productionK D Chavin, L Qin, J Lin, et al.
BMC Nephrology|October 11, 2013
An update on the impact of pre-transplant transfusions and allosensitization on time to renal transplant and on allograft survivalJuan C Scornik, Jonathan S Bromberg, Douglas J Norman, et al.
ACS Biomaterials Science & Engineering|December 10, 2020
Engineering Strategies to Improve Islet Transplantation for Type 1 Diabetes TherapyAlisa M White, James G Shamul, Jiangsheng Xu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 2, 2002
L-selectin-dependent lymphoid occupancy is required to induce alloantigen-specific toleranceYalai Bai, Jianhua Liu, Yinong Wang, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 31, 2002
CD2 is a dominant target for allogeneic responsesYalai Bai, Shuang Fu, Shaun Honig, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 1, 1994
Prevalence of p53 mutations in patients with squamous cell carcinoma of the esophagusC E Gates, C E Reed, J S Bromberg, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 5, 2003
Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxisEnver Akalin, Vinita Sehgal, Scott Ames, et al.
Neuron|June 12, 2021
A prefrontal network integrates preferences for advance information about uncertain rewards and punishmentsAhmad Jezzini, Ethan S Bromberg-Martin, Lucas R Trambaiolli, et al.
Human Gene Therapy|December 31, 1997
Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expressionL Qin, Y Ding, D R Pahud, et al.
Human Gene Therapy|July 20, 1997
Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigenL Qin, Y Ding, D R Pahud, et al.
Pageof 36